Germinomatous Germ Cell Tumor

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-01-28
Clinical Trial Update: Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors [Phase 2]
Phase 2 clinical trial evaluating the combination of durvalumab and tremelimumab for relapsed/refractory germ cell tumors; the study is curr…